Merz is an independent German pharmaceutical company with its own research and development, focused on drugs for the treatment of illnesses in the fields of neurology and psychiatry. Another field of competence is the clinical and aesthetic dermatology.
19.02.2010
Merz to complete Acquisition of BioForm Medical FRANKFURT, Germany and SAN MATEO, California – February 19, 2010 -- Merz Pharma Group announced today that the subsequent offering period of the tender offer by Merz GmbH & Co. KGaA (“Merz”) and its acquisition subsidiary to purchase all of the outstanding shares of common stock of BioForm Medical, Inc. (Nasdaq: BFRM) at a price of $5.45 per share, net to the seller in cash (without interest thereon and less any required withholding tax) expired as scheduled at 12:00 midnight, Eastern Standard Time, on February 18, 2010.
Merz counts as one of the leading organizations for Alzheimer's research worldwide. Further focal points of its research include depression, dystonia, Parkinson's disease and tinnitus.
Merz is an innovative product partner of any medical doctor specializing in aesthetic dermatology and/or plastic surgery by offering reliable products for the treatment of wrinkles and aging of the skin. In addition Merz offers products for the treatment of hair loss, scars, and acne.
The Merz Spezial® and tetesept® brands stand for innovative health, beauty and wellness products developed and distributed by Merz Consumer Care.
Last update: 19 Feb 2010, 12:53
produced by GPM mbH
new user
URL: http://www.merz.com/ Last update: 19.02.2010, 12:53 Uhr © 2010 Merz. All rights reserved.